GH Axis · Placeholder catalog data
CP10 / CP20 (Performance)
Also known as CJC-1295 w/o DAC + Ipamorelin
A two-compound GH-axis stack pairing CJC-1295 without DAC with Ipamorelin for coordinated GHRH and GHS-R1a pathway coverage.
160 credits
Paid from your credit pool at checkout. Bulk quantities discount automatically.
Available variants
Pricing and fulfillment information is placeholder data.
| Amount | SKU | Credits | MSRP | Availability | Margin estimate |
|---|---|---|---|---|---|
| 10 mg | PTS-CP10-10 | 32 credits | $79 | Ready | 59% estimate |
| 20 mg | PTS-CP20-20 | 51 credits | $129 | Ready | 60% estimate |
Margin estimate treats 1 credit as $1 and compares estimated wholesale credit cost with placeholder MSRP. It excludes shipping, taxes, and other costs.
Buy more, save more
Quantity breaks apply per line item and are deducted automatically at checkout.
| Quantity per line | Discount | Example (10 mg unit) |
|---|---|---|
| 10+ units | 5% off | 10 × 32 credits → 304 credits |
| 25+ units | 10% off | 25 × 32 credits → 720 credits |
| 50+ units | 15% off | 50 × 32 credits → 1,360 credits |
| 100+ units | 20% off | 100 × 32 credits → 2,560 credits |
Specifications
- Formula
- Composite blend of CJC-1295 w/o DAC and Ipamorelin
- Molecular weight
- 4079.82 g/mol
- Sequence
- CJC-1295 w/o DAC · Ipamorelin
- Purity
- Each component ≥99%
- Appearance
- White lyophilized peptide blend
- Storage
- Store lyophilized at −20 °C, protected from light and moisture
Quality record
COA status
COA listedLot PTS-CP10-2607
Placeholder reference. Verify the active lot before ordering.
Research background
CP10 and CP20 are Performance Stack formats combining CJC-1295 without DAC and Ipamorelin in one vial.
CJC-1295 w/o DAC is a modified GRF(1-29) analog discussed in GHRH receptor literature, while Ipamorelin is a selective growth hormone secretagogue receptor agonist.
CP10 contains CJC-1295 w/o DAC 5mg with Ipamorelin 5mg. CP20 doubles the same composition, pairing CJC-1295 w/o DAC 10mg with Ipamorelin 10mg.
Mechanism: The stack is designed around complementary GH-axis signaling through GHRH receptor activity and GHS-R1a pathway engagement.
Research use only
For research use only. Not for human or veterinary use.